EIR Xellia Pharmaceuticals USA Jan 2020

Cassandra Abellard FDA, Lauren Howard FDA, Wendy Tan FDA$595.00 - Available Now

FDA investigators audited the Xellia Pharmaceuticals USA - Bedford, OH, United States facility and issued inspectional observation (via FDA 483) on 31 Jan 2020.

Product details

  • Category:
  • Inspection end: 31 Jan 2020
  • Location: Bedford, United States
  • FEI: 3012279857
Add To Cart